We hypothesize that (1) depression during pregnancy and prenatal Pb exposure will jointly contribute to worse infant outcomes than either exposure independently, (2) gestational Pb and depression exposures will jointly contribute to NR3C1 methylation signatures at birth, and (3) NR3C1 signatures at birth will be associated with infant outcomes. This evidence concerns the gene NR3C1 and depressive symptom measurement.